Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 32.10
0.00 (0.00%)
Sep 24, 2026, 1:30 PM CST
Sinphar Pharmaceutical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,451 | 3,371 | 3,151 | 2,963 | 2,857 | 2,434 |
Revenue Growth | 7.08% | 7.00% | 6.33% | 3.72% | 17.39% | 1.89% |
Gross Profit Gross Profit Growth | 1,538 | 1,459 | 1,240 | 1,094 | 1,093 | 888.71 |
Operating Income Operating Income Growth | 410.47 | 419.39 | 297.16 | 288.74 | 198.63 | -182.77 |
Net Income Net Income Growth | 351.67 | 365.75 | 304.71 | 375.17 | 224.64 | -38.14 |
Earnings Per Share EPS Growth | 1.74 | 1.81 | 1.51 | 1.86 | 1.11 | -0.19 |
EPS Growth | 13.16% | 20.00% | -18.84% | 66.91% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Efficacy Medication Efficacy Medication Growth | 2,114 | 2,071 | 2,069 | 1,904 | 1,896 | 1,575 |
Functional Food Functional Food Growth | 1,211 | 1,185 | 973.17 | 948.38 | 860.09 | 763.55 |
Others Others Growth | 126.01 | 115.73 | 108.88 | 110.57 | 100.09 | 94.75 |
Total Total Growth | 3,451 | 3,371 | 3,151 | 2,963 | 2,857 | 2,434 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,594 | 994.63 | 1,178 | 1,081 | 1,244 | 1,245 |
Total Debt Total Debt Growth | 2,046 | 1,510 | 1,902 | 1,945 | 1,913 | 2,134 |
Net Cash (Debt) Net Cash Growth | -451.57 | -515.14 | -724.46 | -863.71 | -668.74 | -889.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.23 | -2.55 | -3.59 | -4.28 | -3.31 | -4.41 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 598.31 | 584.66 | 593.51 | 296.37 | 425.3 | 135.54 |
Capital Expenditures CapEx Growth | -266.51 | -194.71 | -240.44 | -295.51 | -141.48 | -146.18 |
Free Cash Flow Free Cash Flow Growth | 331.81 | 389.95 | 353.08 | 0.86 | 283.82 | -10.64 |
Free Cash Flow Growth | -18.43% | 10.45% | 40955.23% | -99.70% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.58% | 43.29% | 39.37% | 36.92% | 38.25% | 36.52% |
Operating Margin | 11.90% | 12.44% | 9.43% | 9.74% | 6.95% | -7.51% |
Pretax Margin | 11.78% | 11.91% | 9.75% | 10.32% | 8.58% | -7.58% |
Profit Margin | 10.19% | 10.85% | 9.67% | 12.66% | 7.86% | -1.57% |
FCF Margin | 9.62% | 11.57% | 11.21% | 0.03% | 9.93% | -0.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.943 | 0.943 | 0.898 | 0.832 | 0.832 | 0.166 |
Dividend Per Share Growth | 5.00% | 5.00% | 8.01% | 0% | 399.94% | 0% |
Dividend Yield | 2.94% | 3.38% | 3.41% | 3.22% | 3.40% | 0.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.49 | 15.86 | 18.55 | 15.18 | 24.75 | - |
Forward PE | - | 16.95 | 17.05 | 62.19 | 62.19 | 62.19 |
P/FCF Ratio | 19.50 | 14.88 | 16.01 | 6621.12 | 19.59 | - |
PS Ratio | 1.88 | 1.72 | 1.79 | 1.92 | 1.95 | 1.99 |